Cargando...

Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events

PURPOSE: Biological therapies are currently the mainstay in the treatment of patients with inflammatory bowel diseases (IBD). Several factors are known to influence the efficacy and tolerability of biologicals, such as CRP levels or previous biological use. Whether patient sex affects the efficacy o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Colorectal Dis
Main Authors: Lie, Mitchell R. K. L., Paulides, Emma, van der Woude, C. Janneke
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340671/
https://ncbi.nlm.nih.gov/pubmed/32592091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00384-020-03663-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!